Limits of [18F]-FLT PET as a Biomarker of Proliferation in Oncology

Imaging Colon Cancer Response Following Treatment with AZD1152: A Preclinical Analysis of [18F]Fluoro-2-deoxyglucose and 3'-deoxy-3'-[18F]Fluorothymidine Imaging

(2011) M. A. Moroz et al.   CLINICAL CANCER RESEARCH

Monitoring cellular accumulation of 3′-deoxy-3′-fluorothymidine (FLT) and its monophosphate metabolite (FLT-MP) by LC–MS/MS as a measure of cell proliferation in vitro

(2011) Wenlin Li et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Tumor 3'-Deoxy-3'-18F-Fluorothymidine (18F-FLT) Uptake by PET Correlates with Thymidine Kinase 1 Expression: Static and Kinetic Analysis of 18F-FLT PET Studies in Lung Tumors

(2011) J. S. Brockenbrough et al.   JOURNAL OF NUCLEAR MEDICINE

Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer

(2009) C. Shah et al.   CLINICAL CANCER RESEARCH

Using Dual-Tracer PET to Predict the Biologic Behavior of Human Colorectal Cancer

(2009) W. Hui et al.   JOURNAL OF NUCLEAR MEDICINE

Detection of colorectal cancer using 18F-FLT PET: comparison with 18F-FDG PET

(2009) Yuka Yamamoto et al.   NUCLEAR MEDICINE COMMUNICATIONS

Molecular Imaging of Therapeutic Response to Epidermal Growth Factor Receptor Blockade in Colorectal Cancer

(2008) H. C. Manning et al.   CLINICAL CANCER RESEARCH

Kinetic Modeling of 3'-Deoxy-3'-18F-Fluorothymidine for Quantitative Cell Proliferation Imaging in Subcutaneous Tumor Models in Mice

(2008) S. J. Kim et al.   JOURNAL OF NUCLEAR MEDICINE